NCPAP在治疗新生儿急性呼吸衰竭中的应用价值

目的：探讨鼻塞持续正压通气(NCPAP)治疗新生儿急性呼吸衰竭的临床应用价值。方法：选取我院2008 年2 月至2014 年5月接收确诊的新生儿急性呼吸衰竭98 例,根据治疗方法不同均分为对照组和治疗组,每组49 例,对照组采用持续头罩吸氧治疗,治疗组采用鼻塞持续正压无创通气治疗,对比分析两组患儿的治疗效果。结果：治疗24 h 后,治疗组患儿的呼吸、心率、PaO2和PaCO2临床指标改善程度要高于对照组(P<0.05),且治疗组的治愈率高于对照组(89.4 %>67.4 %,X2=3.671,P<0.05),同时并发症的发生率低于对照组(P<0.05)。结论：NCPAP 能够有效地治疗新生儿急性呼吸衰竭,同时减少并发症的发生,值得临床进一步推广与应用。

Application of NCPAP in the Treatment of Acute Respiratory Failure in Neonates

Objective:To explore the clinical application value of NCPAP (Nasal Continuous Positive Airway Pressure) in thetreatment of neonatal acute respiratory failure.Methods:98 cases in our hospital from February 2008 to May 2014 which were selected,then were equally into the treatment group and the control group according to the different treatment methods, with 49 cases in eachgroup. The control group was treated with continuous mask oxygen, the treatment group was treated with nasal continuous positivepressure ventilation (NCPAP). The curative effect of the two groups were compared and analyzed.Results:At 24 h after treatment, theclinical indexes of respiratory, heart rate, PaO2 and PaCO2 in the treatment group were improved more obviously than that of the controlgroup (P<0.05), and the cure rate was in treatment group than that of the control group (89.4 %>67.4 %, X2=3.671, P<0.05), and theincidence of complications was lower than that of the control group (P<0.05).Conclusion:NCPAP can effectively treat neonatal acuterespiratory failure, and reduce the occurrence of complications, it is worthy of further clinical promotion and application.